Datu Oto, Amsia B.
HRN: 19-26-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2023
METRONIDAZOLE 500MG (TAB)
03/18/2023
03/25/2023
ORAL
500mg
TID
S/P LTCS MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes